Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Roche Holding AG
  6. News
  7. Press Releases
    ROG   CH0012032048

ROCHE HOLDING AG

(ROG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société ROCHE HOLDING AG
06/22Insulin pump Accessories Market Development, Outline, Competitive perspective..
AQ
06/17ROCHE  : Check You Employment Agreement's Restrictive Covenant
AQ
06/16ROCHE  : Atea Pharmaceuticals Announces Achievement of AT-527 Development Milest..
AQ
06/15ROCHE  : data at EAN 2021 showcase significant impact of therapies across divers..
AQ
06/14CHUGAI PHARMACEUTICAL  : Files New Drug Application in Japan for Faricimab, the ..
AQ
06/14PTC THERAPEUTICS  : Pre-symptomatic Infants with Spinal Muscular Atrophy Achieve..
AQ
06/14ROCHE  : announces data at EHA2021 reinforcing efficacy of Venclexta/Venclyxto c..
AQ
06/11GENENTECH  : Announces Data at EHA2021 Reinforcing Efficacy of Venclexta Combina..
BU
06/11ROCHE  : announces data at EHA2021 reinforcing efficacy of Venclexta/Venclyxto c..
AQ
06/11ROCHE  : New Roche data for Evrysdi show improved motor function in pre-symptoma..
AQ
06/11ROCHE  : New Genentech Data for Evrysdi (risdiplam) Show Improved Motor Function..
BU
06/09ROCHE  : Accu-Chek® Inform II Hospital Blood Glucose System now approved by Heal..
AQ
06/08CHOROIDEREMIA PIPELINE : Emerging Therapies and Key pharma players involved by D..
AQ
06/08ROCHE  : obtains CE mark for the SARS-CoV-2 Antigen Self Test Nasal allowing for..
AQ
06/07REMINDER : Invitation to Roche's virtual event on key Evrysdi data presented at ..
PU
06/07ROCHE  : Genentech Presents Latest Advances With Immunotherapies in Non-Hodgkin'..
AQ
06/07ROCHE  : Dosage Regimens Affirmed In Canada Again
AQ
06/04GENENTECH  : Presents Latest Advances With Immunotherapies in Non-Hodgkin's Lymp..
BU
06/04ROCHE  : presents latest advances with immunotherapies in non-Hodgkin lymphoma
AQ
06/03ROCHE  : Cancer Inclusion Into NHIs Would Reduce Economic Burden - Bagudu
AQ
06/03MEDULLOBLASTOMA PIPELINE : Emerging Therapies and Key pharma players involved by..
AQ
05/31REMINDER : Invitation to Roche's virtual event on key oncology data presented at..
PU
05/26ROCHE  : Invitation to Roche's virtual event on key Evrysdi data presented at th..
PU
05/25ROCHE  : European Commission approves Venclyxto-based combinations for adults wi..
AQ
05/21ONCOLYTICS BIOTECH  : Announces Clinical and Biomarker Data Demonstrating Clinic..
AQ
05/20ROCHE  : Pivotal Phase III Data at ASCO Show Genentech's Tecentriq Helps Certain..
AQ
05/20ROCHE  : Pivotal Phase III data at ASCO show Roche's Tecentriq helps certain peo..
AQ
05/19ROCHE  : Pivotal Phase III Data at ASCO Show Genentech's Tecentriq Helps Certain..
BU
05/18ROCHE  : Diagnostics Canada partners with Canadian Blood Services to include Ele..
AQ
05/11PROTHENA  : Announces achievement of $60 million milestone from roche for first ..
AQ
05/11ROCHE  : to present data from one of the most comprehensive oncology portfolios ..
AQ
05/11GENENTECH  : to Present Data From One of the Most Comprehensive Oncology Portfol..
BU
05/10CHUGAI PHARMACEUTICAL  : Discontinues Marketing of Photodynamic Diagnostic Agent..
AQ
05/05ROCHE  : Tecentriq approved by European Commission as a first-line monotherapy t..
AQ
04/30ROCHE  : Invitation to Roche's virtual event on key oncology data presented at A..
PU
04/28ROCHE  : FDA Advisory Committee Votes in Favor of Maintaining Accelerated Approv..
BU
04/28ROCHE  : US FDA Advisory Committee votes in favour of maintaining accelerated ap..
AQ
04/28ROCHE  : FDA Advisory Committee Votes in Favor of Maintaining Accelerated Approv..
AQ
04/28ROCHE  : launches new ways to use their cardiovascular tests empowering clinicia..
AQ
04/27ROCHE  : FDA Advisory Committee Votes in Favor of Maintaining Accelerated Approv..
BU
04/27ROCHE  : US FDA Advisory Committee votes in favour of maintaining accelerated ap..
AQ
04/26ABBVIE  : Receives Positive CHMP Opinion for VENCLYXTO (venetoclax) as a Combina..
AQ
04/23ROCHE  : announces positive CHMP opinion for Venclyxto-based combinations in cer..
PU
04/23ROCHE  : CHMP recommends EU approval of Roche's ENSPRYNG (satralizumab) for adul..
AQ
04/23ROCHE  : receives FDA approval for first companion diagnostic to identify endome..
AQ
04/22CHUGAI PHARMACEUTICAL  : Supports the Japan Climate Initiative's Calling to Rais..
AQ
04/22ROCHE  : purchases shares in tender offer for GenMark Diagnostics, Inc.
AQ
04/21ROCHE  : Q1 2021 Investor update
PU
04/21ROCHE  : Q1 2021 Presentation without appendix
PU
04/21ROCHE  : reports solid results in the first quarter of 2021
AQ
04/19ROCHE  : New data for Roche's OCREVUS (ocrelizumab) reinforce significant benefi..
AQ
04/16ROCHE  :  New Data for Genentech's Ocrevus (ocrelizumab) Reinforce Significant B..
BU
04/16ROCHE  : New data for Roche's OCREVUS (ocrelizumab) reinforce significant benefi..
AQ
04/15ROCHE  : FDA Approves Xolair (omalizumab) Prefilled Syringe for Self-Injection A..
PU
04/15GENENTECH  : 's Evrysdi Continues to Improve Motor Function and Survival in Babi..
BU
04/15ROCHE  : Evrysdi continues to improve motor function and survival in babies with..
AQ
04/14REMINDER : Invitation to Roche's First Quarter Sales 2021 Webinar
PU
04/13ROCHE  : FDA Approves Xolair (omalizumab) Prefilled Syringe for Self-Injection A..
AQ
04/12ROCHE  :  FDA Approves Xolair (omalizumab) Prefilled Syringe for Self-Injection ..
BU
04/12ROCHE  : Phase III prevention trial showed subcutaneous administration of invest..
AQ
04/09CHUGAI PHARMACEUTICAL  : Conducts Disease Awareness Activities Internally and Ex..
AQ
04/08ROCHE  : New Genentech Data at 2021 AAN Highlight Impact and Breadth of Expandin..
BU
04/08ROCHE  : New Roche data at 2021 AAN highlight impact and breadth of expanding ne..
AQ
04/07ROCHE  : MHRA - Early Access continues during the coronavirus (COVID-19) pandemi..
AQ
04/07ROCHE  : launches Elecsys Anti-p53 immunoassay to aid diagnosis of various cance..
AQ
04/06NEW ROCHE'S ELECSYS® ANTI-SARS-COV-2 : A major addition to Roche's innovative CO..
AQ
04/01CHUGAI PHARMACEUTICAL  : Mar 31, 2021Chugai Organizes the Second Workshop on Mul..
AQ
03/31ROCHE  : Evrysdi approved by European Commission as first and only at home treat..
AQ
03/31PTC THERAPEUTICS  : Announces the European Approval of Evrysdi for the Treatment..
AQ
03/31ROCHE  : Evrysdi™ approved for treatment of spinal muscular atrophy in Eur..
AQ
03/31ROCHE  : launches Elecsys Epstein-Barr Virus (EBV) immunoassay panel to improve ..
AQ
03/30ROCHE  : Evrysdi approved by European Commission as first and only at home treat..
AQ
03/26ROCHE  : receives positive CHMP opinion for Tecentriq as a first-line monotherap..
AQ
03/25ROCHE  : commences tender offer for all shares of GenMark Diagnostics, Inc. for ..
AQ
03/24CHUGAI : Polivy approved for treatment of relapsed or refractory diffuse large B..
PU
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on ROCHE HOLDING AG